Brief: ARS Pharmaceuticals Reports Q3 2024 Financial Results And Provides Business Updates
13/11/2024 12:56
Nov 13 (Reuters) - ARS Pharmaceuticals Inc SPRY.O :
* ARS PHARMACEUTICALS REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* ARS PHARMACEUTICALS: PDUFA TARGET DATE SET FOR MARCH 6,
2025
* ARS PHARMACEUTICALS: CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS WERE $204.6 MILLION AS OF SEPTEMBER 30, 2024
Source text: urn:newsml:reuters.com:*:nGNX89y5tN
Further company coverage: SPRY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle